Petmed Express Inc banner

Petmed Express Inc
NASDAQ:PETS

Watchlist Manager
Petmed Express Inc Logo
Petmed Express Inc
NASDAQ:PETS
Watchlist
Price: 2.25 USD -2.17% Market Closed
Market Cap: $48.2m

EV/GP

0.4
Current
38%
Cheaper
vs 3-y average of 0.6

Enterprise Value to Gross Profit (EV/GP) ratio compares a company`s total enterprise value to its gross profit. It shows how much investors are paying for each dollar of the company`s gross profit, including both equity and debt.

EV/GP
0.4
=
Enterprise Value
$33m
/
Gross Profit
$57.3m

Enterprise Value to Gross Profit (EV/GP) ratio compares a company`s total enterprise value to its gross profit. It shows how much investors are paying for each dollar of the company`s gross profit, including both equity and debt.

EV/GP
0.4
=
Enterprise Value
$33m
/
Gross Profit
$57.3m

Valuation Scenarios

Petmed Express Inc is trading below its 3-year average

If EV/GP returns to its 3-Year Average (0.6), the stock would be worth $3.6 (60% upside from current price).

Statistics
Positive Scenarios
4/4
Maximum Downside
No Downside Scenarios
Maximum Upside
+1 604%
Average Upside
760%
Scenario EV/GP Value Implied Price Upside/Downside
Current Multiple 0.4 $2.25
0%
3-Year Average 0.6 $3.6
+60%
5-Year Average 2.9 $16.89
+651%
Industry Average 3.1 $18.53
+724%
Country Average 6.5 $38.34
+1 604%

Forward EV/GP
Today’s price vs future gross profit

Not enough data available to calculate forward EV/GP

Peer Comparison

All Multiples
EV/GP
P/E
All Countries
Close

Market Distribution

Lower than 99% of companies in the United States of America
Percentile
1st
Based on 9 428 companies
1st percentile
0.4
Low
0 — 4.2
Typical Range
4.2 — 10.6
High
10.6 —
Distribution Statistics
the United States of America
Min 0
30th Percentile 4.2
Median 6.5
70th Percentile 10.6
Max 1 764 211.7

Petmed Express Inc
Glance View

Market Cap
48.2m USD
Industry
Retail

PetMed Express, Inc. engages in the provision of markets prescription and non-prescription pet medications, health products and supplies for dogs and cats. The company is headquartered in Delray Beach, Florida and currently employs 212 full-time employees. The company went IPO on 2000-04-06. The firm's product line contains approximately 3,000 SKUs of pet medications, health products, and supplies. The company offers various pet supplies, including food, beds, crates, stairs and other pet supplies. The firm's products include Non-Prescription Medications (OTC) and supplies, and Prescription Medications (Rx). OTC and supplies include flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies. Rx includes heartworm and flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.

PETS Intrinsic Value
1.73 USD
Overvaluation 23%
Intrinsic Value
Price $2.25
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett